Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies. - Wikidata - awgldk - TriplyDB

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.

http://www.wikidata.org/entity/Q37263149

about

Multidisciplinary Canadian consensus recommendations for the management and treatment of hepatocellular carcinoma Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma Sorafenib for the treatment of hepatocellular carcinoma with portal vein tumour thrombosis: a systematic review of comparative studies Molecular classification and novel targets in hepatocellular carcinoma: recent advancements MicroRNAs in nonalcoholic fatty liver disease: novel biomarkers and prognostic tools during the transition from steatosis to hepatocarcinoma.Overview of data-synthesis in systematic reviews of studies on outcome prediction models.Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment.Eastern Asian expert panel opinion: designing clinical trials of molecular targeted therapy for hepatocellular carcinoma ABO blood type correlates with survival in hepatocellular carcinoma following hepatectomy.Overexpression of sineoculis homeobox homolog 1 predicts poor prognosis of hepatocellular carcinoma.Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort.Utilisation of search filters in systematic reviews of prognosis questions.Prognostic prediction across a gradient of total tumor volume in patients with hepatocellular carcinoma undergoing locoregional therapy GIDEON (Global Investigation of therapeutic DEcisions in hepatocellular carcinoma and Of its treatment with sorafeNib): second interim analysis.MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma High KIF18A expression correlates with unfavorable prognosis in primary hepatocellular carcinoma Early finding of chest wall metastasis of hepatocellular carcinoma in a woman by fluorodeoxyglucose-positron emission tomography scan: a case report A new model to estimate prognosis in patients with hepatocellular carcinoma after Yttrium-90 radioembolization.Incidental tumor necrosis caused by the interventional alteration of hepatic arterial flow in patients with advanced hepatocellular carcinoma Concurrent activation of acetylation and tri-methylation of H3K27 in a subset of hepatocellular carcinoma with aggressive behavior Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study.Prognostic index for portal vein tumor thrombosis in patients with hepatocellular carcinoma treated with radiation therapy.Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma and Child-Pugh A or B cirrhosis.Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinib.Prognostic roles of preoperative α-fetoprotein and des-γ-carboxy prothrombin in hepatocellular carcinoma patients.Prognostic effect of preoperative sequential transcatheter arterial chemoembolization and portal vein embolization for right hepatectomy in patients with solitary hepatocellular carcinoma Circulating tumor cells measurements in hepatocellular carcinoma.Neutrophil-to-lymphocyte ratio for the prognostic assessment of hepatocellular carcinoma: A systematic review and meta-analysis of observational studies Predictive value of ¹⁸F-fluorodeoxyglucose PET/CT for transarterial chemolipiodolization of hepatocellular carcinoma.Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.A comparison of clinical manifestations and prognoses between patients with hepatocellular carcinoma and Child-Pugh scores of 5 or 6.Nomogram prediction of individual prognosis of patients with hepatocellular carcinoma.Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection.Clinicopathological indices to predict hepatocellular carcinoma molecular classification Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma with Portal Vein Thrombosis: Impact of Early Response to 4 Weeks of Treatment.Association of Histone Methyltransferase G9a and Overall Survival After Liver Resection of Patients With Hepatocellular Carcinoma With a Median Observation of 40 Months Survival Analysis of Hepatocellular Carcinoma: A Comparison Between Young Patients and Aged Patients.Alpha-fetoprotein: a controversial prognostic biomarker for small hepatocellular carcinoma A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.

P2860

Q24635267-55EF0FA0-FD89-4F5E-B0DB-F3AA24472943 Q26772324-82F524D8-16E9-4600-BAC2-514B2720E6F2 Q26777892-E8838A70-E864-422A-AE32-E30F56842D52 Q28383646-081DA4EC-CFEB-449B-BBF9-F5546EC5216D Q30439971-1D93EAE9-9AF3-43CF-A80F-D9B466D380B6 Q30599542-0DB1B8D6-107E-45B1-9E30-6EF1B27D0313 Q31111026-E2A57A6F-2DF3-4F4B-B883-3564433CF938 Q33627217-B96EF8EC-9807-44C7-810D-32CB46ECE9A5 Q33742856-4B8D8F58-3F50-4457-A690-9E4CBBFCE4C1 Q33861119-10635057-A8E9-4259-9289-536564423417 Q33898828-44CD3233-949F-4232-A170-83BE82133AF9 Q34446810-88F4C49B-1527-4E4C-A680-86B433864A1D Q34486542-47EFAA08-6F37-4257-B13A-B0F52AA64166 Q34498762-400ADC41-FF76-45A5-ACC4-82872744559B Q34693220-C7567EDE-B545-4CE1-9F6D-8F4B4E4ACC1E Q34745477-5F7781A5-2DF9-4B0B-9A5F-5B5B57443415 Q34786421-BDEA9F90-F4D9-44BA-A8BF-8A12845D2522 Q34950780-800DFD12-1565-466F-909F-277D3B94C4D9 Q35075280-E92EBD84-2AA7-4B80-8AA9-798E98DD91E8 Q35092567-5D46B8AA-B6BC-4346-BAFF-7185FA044CE9 Q35116342-90C8C932-4DF8-4D9C-AFDD-6A25BD0C709D Q35156568-315D8703-C736-42B4-AEFD-61A6CF61940D Q35158760-353FC67E-FE36-4428-9F59-A1B9C10DFF76 Q35167764-F025F187-27DC-4C6E-BA18-0E2F654F8D8C Q35184195-346F3987-90BC-48CE-A315-D3F269F464E7 Q35534064-3F0D7BBA-C4AC-4EF1-90D1-6136FE643FA0 Q35826267-8D01A1E8-9CB8-406E-A561-13A8AC4C899F Q36011412-CDF00B6C-7F6C-4129-9751-2FADFFF4B75F Q36052780-BCCFB9EF-6D24-454B-AB19-3F29908D203C Q36082172-127E6DCF-2A38-4DFE-9BEB-911BA15A5608 Q36092123-D7161862-1A20-4798-823A-B053E36BE1F7 Q36151682-DD6F2231-95E0-4275-9B99-E8AF34F20731 Q36265439-B7B2181C-5745-4F4B-BBCF-7E1A22345CAC Q36326364-C822295F-9644-4141-B69F-9FE9E72679BF Q36359814-B8FB35CE-F17F-4C3B-A736-5A17D8D2F185 Q36423166-65C29225-BC60-4E50-B336-B6B562112DAA Q36478238-AA43E130-0817-41EB-92DB-CEE61C6A8576 Q36523063-E034AD1D-ECD0-4751-86A9-C0D3EDB35409 Q36561634-53FC6868-2F8B-478A-97E1-6279EB2952D3 Q36562391-DF656666-0D9F-408F-8899-2DDA1AD7E053

P2860

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.

http://www.wikidata.org/entity/Q37263149

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 24 December 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.

@en

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.

@nl

type

label

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.

@en

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.

@nl

prefLabel

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.

@en

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.

@nl

P1433

Q37263149-0CAAC935-C6E5-42E0-8ACD-6801646D2D76

P1476

Q37263149-3958AF34-1FAE-43C5-AE73-AAEFC64BAD71

P2093

Q37263149-3BB29668-A6E4-4176-A291-192ACE766453

Q37263149-4CD9D922-DFCD-466F-B2D3-F48146EFE90E

P275

Q37263149-07AF0623-155F-4BA5-81E9-1398DF1804B7

P2860

Q37263149-02EFF898-00DD-4A56-833E-3A8ABB042810

Q37263149-04207337-EA54-4C76-A324-D8CE2E4BF0D7

Q37263149-06A57FDE-9221-4E9E-BC6A-4275429C75AD

Q37263149-08B32629-462B-4EDD-AC4F-3DE2B10F8286

Q37263149-103607CA-18FC-41E8-B609-B3EB117674B2

Q37263149-12B325CA-AACE-4DE8-A7B0-94FB6990A9CB

Q37263149-137B2477-14C0-4326-A95E-55BF8D5C26B7

Q37263149-1560E587-6F78-44D0-9F0B-85BFAF96F4F2

Q37263149-172BEC3C-508E-4122-AB2A-3B72698DE898

Q37263149-1C92B7BC-C46D-4616-B5E0-432E99E46227

P304

Q37263149-086D21B3-46BC-44F4-9C59-F72E6645218C

P31

Q37263149-D307FBE6-7C1A-4C38-85C9-A47726686A40

Q37263149-E4F82011-8D53-4778-9EAF-8A7333E30015

P356

Q37263149-BE30206D-A93C-48EF-AE8D-D2318149B1DC

P433

Q37263149-7AFA5E9E-EEF1-46F4-98E0-6442A34DF7AB

P478

Q37263149-0D71939B-7B86-44AA-8434-DC289A6D07FB

P5008

Q37263149-07275195-7B60-4C62-9915-DE9AC5D72C6D

P577

Q37263149-5A6ECF6C-64E2-4D6D-A644-A5001125A711

Q37263149-725C15DE-98F7-4F0F-8D8C-C692489ED1D1

P5875

Q37263149-7FDFDE03-7E87-4FF7-AE7F-591EEB647A41

P698

Q37263149-D0155DAF-09EC-4B51-A213-8A0617C347D6

P921

Q37263149-0305B025-EFEF-4E55-B70E-ECD873AC28DC

Q37263149-0C20D7DE-E17A-4964-9C63-F1A10B0BC849

Q37263149-DD6385B1-79B8-41A5-A259-86CB81891BAC

P932

Q37263149-A36EC615-3B8D-4E8E-A222-5811701F01E7

P356

J.1478-3231.2008.01957.X

P1433

Liver International

P1476

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies.

@en

P2093

Guadalupe Garcia-Tsao

http://www.w3.org/2001/XMLSchema#string

Puneeta Tandon

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 2.5 Unported

P2860

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

Prognosis of hepatocellular carcinoma: the BCLC staging classification

Assessing the generalizability of prognostic information.

Hepatocellular carcinoma in extremely elderly patients: an analysis of clinical characteristics, prognosis and patient survival

Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials.

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients.

Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies.

A new prognostic classification for predicting survival in patients with hepatocellular carcinoma. Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire.

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation.

P304

502-510

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1478-3231.2008.01957.X

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P5008

P577

2008-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2009-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23784552

http://www.w3.org/2001/XMLSchema#string

P698

19141028

http://www.w3.org/2001/XMLSchema#string

P921

hepatocellular carcinoma

liver cirrhosis

P932

2711257

http://www.w3.org/2001/XMLSchema#string